In a recent MedTech France article, our CEO Nicolas Wolikow highlights a fundamental shift: precision medicine is becoming actionable. The convergence of multi-omics data, large-scale computing and AI is finally turning precision medicine into an operational reality to the benefit of all patients.
The high volume of granular data improves our ability to structure, interpret and activate it. We are now able to:
• Capture tumor heterogeneity at unprecedented resolution
• Understand and analyse complex cellular interactions in real time
• Move from statistical averages to true biological individuality
This is a paradigm shift with an impact on research, clinical decision-making, hospital organization and the way we design and deliver therapies. For years, precision medicine has been more promise than practice. That is now changing, enabling us to turn patient complexity into actionable insights.
Updated: April 21, 2026
